Abstract
Background
Uveal melanoma (UM) is the most common primary intraocular malignancy in adults. Early treatment may improve any chances of preventing metastatic disease, but diagnosis of small UM is challenging. Up to 95 % of all UMs carry somatic mutations in the G-coupled proteins GNAQ and GNA11 promoting anchorage-independent growth and proliferation. About 50 % of UMs are fatal. Once metastatic, patients have limited options for successful therapy.
Methods
We have developed functionalized gold nanoparticles (AuNPs) to visualize transcripts of mutant GNAQ mRNA in living cells. In addition to their suitability as a specific tool for GNAQ mutation detection, we have developed a novel linker that enables conjugation of siRNAs to AuNPs allowing for greater and more rapid intracellular release of siRNAs compared to previously described approaches.
Results
Binding of modified AuNPs to matching target mRNA leads to conformational changes, resulting in a detectable fluorescent signal that can be used for mutation detection in living cells. Knockdown of GNAQ with siRNA-AuNPs effectively reduced downstream signals and decreased cell viability in GNAQ mutant uveal melanoma cells.
Conclusion
AuNPs may in future be developed to serve as sensors for mutations of vital importance. The new release system for siRNA-AuNP improves previous systems, which conceivably will be useful for future therapeutic gene regulatory approaches.
Similar content being viewed by others
References
S. Bakalian, J.-C. Marshall, P. Logan, D. Faingold, S. Maloney, S. Di Cesare, C. Martins, B.F. Fernandes, M.N. Burnier Jr., Clin Cancer Res. Off. J. Am. Assoc. Cancer Res. 14, 951 (2008)
A.Y. Bedikian, S.S. Legha, G. Mavligit, C.H. Carrasco, S. Khorana, C. Plager, N. Papadopoulos, R.S. Benjamin, Cancer 76, 1665 (1995)
P. Butler, D.H. Char, M. Zarbin, S. Kroll, Ophthalmology 101, 710 (1994)
Y.-T. Chen, C.-L. Hsu, S.-Y. Hou, Anal. Biochem. 375, 299 (2008)
J. Conde, A. Ambrosone, V. Sanz, Y. Hernandez, V. Marchesano, F. Tian, H. Child, C.C. Berry, M.R. Ibarra, P.V. Baptista, C. Tortiglione, J.M. de la Fuente, ACS Nano 6, 8316 (2012)
J. Conde, F. Tian, Y. Hernández, C. Bao, D. Cui, K.-P. Janssen, M.R. Ibarra, P.V. Baptista, T. Stoeger, J.M. de la Fuente, Biomaterials 34, 7744 (2013)
B. Damato, J.A. Dopierala, S.E. Coupland, Clin. Cancer Res. 16, 6083 (2010a)
B. Damato, J.A. Dopierala, S.E. Coupland, Clin. Cancer Res. Off. J. Am. Assoc Cancer Res. 16, 6083 (2010b)
B. Damato, J. Dopierala, A. Klaasen, M. van Dijk, J. Sibbring, S.E. Coupland, Invest. Ophthalmol. Vis. Sci. 50, 3048 (2009)
E.M. Damato, B.E. Damato, Ophthalmology 119, 1582 (2012)
M. Diener-West, S.M. Reynolds, D.J. Agugliaro, R. Caldwell, K. Cumming, J.D. Earle, B.S. Hawkins, J.A. Hayman, I. Jaiyesimi, L.M. Jampol, J.M. Kirkwood, W.-J. Koh, D.M. Robertson, J.M. Shaw, B.R. Straatsma, J. Thoma, Collaborative Ocular Melanoma Study Group, Arch. Ophthalmol. 123, 1639 (2005)
Y. Ding, Z. Jiang, K. Saha, C. S. Kim, S. T. Kim, R. F. Landis, and V. M. Rotello, Mol. Ther. J. Am. Soc. Gene Ther. (2014)
J.M. Estrela, A. Ortega, E. Obrador, Crit. Rev. Clin. Lab. Sci. 43, 143 (2006)
P. Ghosh, G. Han, M. De, C.K. Kim, V.M. Rotello, Adv. Drug Deliv. Rev. 60, 1307 (2008)
M. Höglund, D. Gisselsson, G.B. Hansen, V.A. White, T. Säll, F. Mitelman, D. Horsman, Int. J. Cancer 108, 57 (2004)
J. W. Harbour, Am. Soc. Clin. Oncol. Educ. Book ASCO Am. Soc. Clin. Oncol. Meet. 388 (2013)
J.W. Harbour, Methods Mol. Biol. Clifton NJ 1102, 427 (2014)
J.W. Harbour, M.D. Onken, E.D.O. Roberson, S. Duan, L. Cao, L.A. Worley, M.L. Council, K.A. Matatall, C. Helms, A.M. Bowcock, Science 330, 1410 (2010)
Y. He, X. Zhang, S. Zhang, M.K.L. Kris, F.C. Man, A.-N. Kawde, G. Liu, Biosens. Bioelectron. 34, 37 (2012)
D. Hu, S.A. McCormick, Eye Sci. 26, 18 (2011)
J. Kimling, M. Maier, B. Okenve, V. Kotaidis, H. Ballot, A. Plech, J. Phys. Chem. B 110, 15700 (2006)
E. Kujala, T. Mäkitie, T. Kivelä, Invest. Ophthalmol. Vis. Sci. 44, 4651 (2003)
A. Latorre, C. Posch, Y. Garcimartín, A. Celli, M. Sanlorenzo, I. Vujic, J. Ma, M. Zekhtser, K. Rappersberger, S. Ortiz-Urda, and A. Somoza, Nanoscale (2014a)
A. Latorre, C. Posch, Y. Garcimartín, S. Ortiz-Urda, Á. Somoza, Chem. Commun. Camb. Engl. 50, 3018 (2014b)
A. Latorre, C. Posch, Y. Gracimartin, A. Celli, M. Sanlorenzo, I. Vujic, J. Ma, M. Zekhtser, K. Rappersberger, S. Ortiz-Urda, and A. Somoza, Nanoscale (2014c)
J.-S. Lee, J.J. Green, K.T. Love, J. Sunshine, R. Langer, D.G. Anderson, Nano Lett. 9, 2402 (2009)
S.K. Lee, M.S. Han, S. Asokan, C.-H. Tung, Small Weinh. Bergstr. Ger. 7, 364 (2011)
M.D. Onken, L.A. Worley, D.H. Char, J.J. Augsburger, Z.M. Correa, E. Nudleman, T.M. Aaberg Jr., M.M. Altaweel, D.S. Bardenstein, P.T. Finger, B.L. Gallie, G.J. Harocopos, P.G. Hovland, H.D. McGowan, T. Milman, P. Mruthyunjaya, E.R. Simpson, M.E. Smith, D.J. Wilson, W.J. Wirostko, J.W. Harbour, Ophthalmology 119, 1596 (2012)
M.D. Onken, L.A. Worley, E. Person, D.H. Char, A.M. Bowcock, J.W. Harbour, Clin. Cancer Res. Off. J. Am. Assoc Cancer Res. 13, 2923 (2007)
M. Patel, E. Smyth, P.B. Chapman, J.D. Wolchok, G.K. Schwartz, D.H. Abramson, R.D. Carvajal, Clin. Cancer Res. Off. J. Am. Assoc Cancer Res. 17, 2087 (2011)
H. Pópulo, J. Vinagre, J.M. Lopes, P. Soares, Br. J. Ophthalmol. 95, 715 (2011)
A.E. Prigodich, D.S. Seferos, M.D. Massich, D.A. Giljohann, B.C. Lane, C.A. Mirkin, ACS Nano 3, 2147 (2009)
A.G.M. Scholes, B.E. Damato, J. Nunn, P. Hiscott, I. Grierson, J.K. Field, Invest. Ophthalmol. Vis. Sci. 44, 1008 (2003)
C.L. Shields, Arch. Ophthalmol. 127, 989 (2009)
C.L. Shields, H. Demirci, M.A. Materin, B.P. Marr, A. Mashayekhi, J.A. Shields, Can. J. Ophthalmol. J. Can. Ophtalmol. 39, 351 (2004)
C.L. Shields, M. Furuta, A. Thangappan, S. Nagori, A. Mashayekhi, D.R. Lally, C.C. Kelly, D.S. Rudich, A.V. Nagori, O.A. Wakade, S. Mehta, L. Forte, A. Long, E.F. Dellacava, B. Kaplan, J.A. Shields, Arch. Ophthalmol. 127, 989 (2009)
C.L. Shields, A. Ganguly, C.G. Bianciotto, K. Turaka, A. Tavallali, J.A. Shields, Ophthalmology 118, 396 (2011)
C.L. Shields, J.A. Shields, Clin. Dermatol. 27, 122 (2009)
A.D. Singh, L. Bergman, S. Seregard, Ophthalmol. Clin. N. Am. 18, 75 (2005)
K. Sisley, R. Doherty, N.A. Cross, Br. J. Ophthalmol. 95, 620 (2011)
A. Somoza, M. Terrazas, R. Eritja, Chem. Commun. Camb. Engl. 46, 4270 (2010)
T. van den Bosch, E. Kilic, D. Paridaens, A. de Klein, Dermatol. Res. Pract. 2010, 360136 (2010)
C.D. Van Raamsdonk, V. Bezrookove, G. Green, J. Bauer, L. Gaugler, J.M. O’Brien, E.M. Simpson, G.S. Barsh, B.C. Bastian, Nature 457, 599 (2009)
C.D. Van Raamsdonk, K.G. Griewank, M.B. Crosby, M.C. Garrido, S. Vemula, T. Wiesner, A.C. Obenauf, W. Wackernagel, G. Green, N. Bouvier, M.M. Sozen, G. Baimukanova, R. Roy, A. Heguy, I. Dolgalev, R. Khanin, K. Busam, M.R. Speicher, J. O’Brien, B.C. Bastian, N. Engl, J. Med. 363, 2191 (2010)
N.R. Wall, Y. Shi, Lancet 362, 1401 (2003)
Acknowledgments
We thank Bertil Damato and James E. Cleaver for their helpful advice in the elaboration of this manuscript. We further thank Boris Bastian for providing the cell lines used in this study. This work was supported by, the National Institute of Health (1K08CA155035-01A1), the Melanoma Research Alliance, the UCSF Catalyst Program, the Max Kade Foundation, the Verein für Dermatologie Krankenanstalt Rudolfstiftung and the René Touraine Foundation the Ministry of Economy and competitiveness (SAF2010-15440) and IMDEA Nanociencia. We further acknowledge T. Dattels for his generous support.
Coflict of interests
The authors have no conflict of interest. Elements of the structure of gold nanoparticles used in this study are patented: 61/933,881 (US); EP14382033.0 (EU).
Author information
Authors and Affiliations
Corresponding author
Additional information
Christian Posch, Alfonso Latorre, Álvaro Somoza and Susana Ortiz-Urda contributed equally to this work.
Electronic supplementary material
Below is the link to the electronic supplementary material.
ESM 1
(PDF 789 kb)
Rights and permissions
About this article
Cite this article
Posch, C., Latorre, A., Crosby, M.B. et al. Detection of GNAQ mutations and reduction of cell viability in uveal melanoma cells with functionalized gold nanoparticles. Biomed Microdevices 17, 15 (2015). https://doi.org/10.1007/s10544-014-9908-7
Published:
DOI: https://doi.org/10.1007/s10544-014-9908-7